Role of body fat distribution and the metabolic complications of obesity

An upper body/visceral fat distribution in obesity is closely linked with metabolic complications, whereas increased lower body fat is independently predictive of reduced cardiovascular risk. The measured functions of different fat depots with regards to fatty acid storage and release in health and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:The journal of clinical endocrinology and metabolism Ročník 93; číslo 11 Suppl 1; s. S57
Hlavní autor: Jensen, Michael D
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 01.11.2008
Témata:
ISSN:0021-972X
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract An upper body/visceral fat distribution in obesity is closely linked with metabolic complications, whereas increased lower body fat is independently predictive of reduced cardiovascular risk. The measured functions of different fat depots with regards to fatty acid storage and release in health and obesity were reviewed. The adverse effects of experimentally increasing free fatty acid (FFA) concentrations on liver, muscle, pancreatic beta-cell, and endothelial function were noted. The most dramatic abnormality in FFA metabolism is failure to suppress FFA concentrations/adipose tissue lipolysis normally in response to postprandial hyperinsulinemia. Upper body sc fat delivers the majority of FFA to the systemic circulation under postabsorptive and postprandial conditions. In upper body obesity, portal FFA concentrations resulting from both systemic and visceral adipose tissue lipolysis may be significantly greater than arterial FFA concentrations, exposing the liver to even greater amounts of FFA. Visceral fat also releases sufficient IL-6 to increase portal vein IL-6 concentrations, which can affect hepatic metabolism as well. Lower body, upper body sc, and visceral fat depots have unique characteristics with regards to fatty acid metabolism. Selective dysregulation of these depots probably plays an important role with the metabolic complications of obesity.
AbstractList An upper body/visceral fat distribution in obesity is closely linked with metabolic complications, whereas increased lower body fat is independently predictive of reduced cardiovascular risk.CONTEXTAn upper body/visceral fat distribution in obesity is closely linked with metabolic complications, whereas increased lower body fat is independently predictive of reduced cardiovascular risk.The measured functions of different fat depots with regards to fatty acid storage and release in health and obesity were reviewed. The adverse effects of experimentally increasing free fatty acid (FFA) concentrations on liver, muscle, pancreatic beta-cell, and endothelial function were noted.EVIDENCE ACQUISITIONThe measured functions of different fat depots with regards to fatty acid storage and release in health and obesity were reviewed. The adverse effects of experimentally increasing free fatty acid (FFA) concentrations on liver, muscle, pancreatic beta-cell, and endothelial function were noted.The most dramatic abnormality in FFA metabolism is failure to suppress FFA concentrations/adipose tissue lipolysis normally in response to postprandial hyperinsulinemia. Upper body sc fat delivers the majority of FFA to the systemic circulation under postabsorptive and postprandial conditions. In upper body obesity, portal FFA concentrations resulting from both systemic and visceral adipose tissue lipolysis may be significantly greater than arterial FFA concentrations, exposing the liver to even greater amounts of FFA. Visceral fat also releases sufficient IL-6 to increase portal vein IL-6 concentrations, which can affect hepatic metabolism as well.EVIDENCE SYNTHESISThe most dramatic abnormality in FFA metabolism is failure to suppress FFA concentrations/adipose tissue lipolysis normally in response to postprandial hyperinsulinemia. Upper body sc fat delivers the majority of FFA to the systemic circulation under postabsorptive and postprandial conditions. In upper body obesity, portal FFA concentrations resulting from both systemic and visceral adipose tissue lipolysis may be significantly greater than arterial FFA concentrations, exposing the liver to even greater amounts of FFA. Visceral fat also releases sufficient IL-6 to increase portal vein IL-6 concentrations, which can affect hepatic metabolism as well.Lower body, upper body sc, and visceral fat depots have unique characteristics with regards to fatty acid metabolism. Selective dysregulation of these depots probably plays an important role with the metabolic complications of obesity.CONCLUSIONSLower body, upper body sc, and visceral fat depots have unique characteristics with regards to fatty acid metabolism. Selective dysregulation of these depots probably plays an important role with the metabolic complications of obesity.
An upper body/visceral fat distribution in obesity is closely linked with metabolic complications, whereas increased lower body fat is independently predictive of reduced cardiovascular risk. The measured functions of different fat depots with regards to fatty acid storage and release in health and obesity were reviewed. The adverse effects of experimentally increasing free fatty acid (FFA) concentrations on liver, muscle, pancreatic beta-cell, and endothelial function were noted. The most dramatic abnormality in FFA metabolism is failure to suppress FFA concentrations/adipose tissue lipolysis normally in response to postprandial hyperinsulinemia. Upper body sc fat delivers the majority of FFA to the systemic circulation under postabsorptive and postprandial conditions. In upper body obesity, portal FFA concentrations resulting from both systemic and visceral adipose tissue lipolysis may be significantly greater than arterial FFA concentrations, exposing the liver to even greater amounts of FFA. Visceral fat also releases sufficient IL-6 to increase portal vein IL-6 concentrations, which can affect hepatic metabolism as well. Lower body, upper body sc, and visceral fat depots have unique characteristics with regards to fatty acid metabolism. Selective dysregulation of these depots probably plays an important role with the metabolic complications of obesity.
Author Jensen, Michael D
Author_xml – sequence: 1
  givenname: Michael D
  surname: Jensen
  fullname: Jensen, Michael D
  email: jensen@mayo.edu
  organization: Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905, USA. jensen@mayo.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18987271$$D View this record in MEDLINE/PubMed
BookMark eNo1jztPwzAYRT0U0QdszMgTW4rtxK8RVdAiVUJCILFFfnwRrpK4xM7Qf08qynSGe-6V7hLN-tgDQneUrCmj5PHg1owQVVCu-AwtCGG00JJ9zdEypQMhtKp4eY3mVGklmaQLtHuPLeDYYBv9CTcmYx9SHoIdc4g9Nr3H-RtwB9nY2AaHXeyOE805TuditJBCPt2gq8a0CW4vXKHPl-ePza7Yv21fN0_7wnHKRWGBMQpl01SECUctZyCEJqasFCilKwLKa8eNtUKUUjdaWCekLQnzk8k9W6GHv93jEH9GSLnuQnLQtqaHOKZaaDmdl3wS7y_iaDvw9XEInRlO9f939gveVVqJ
CitedBy_id crossref_primary_10_1161_ATVBAHA_117_309759
crossref_primary_10_1016_j_jacl_2015_06_008
crossref_primary_10_1007_s11892_022_01455_2
crossref_primary_10_24171_j_phrp_2017_8_2_06
crossref_primary_10_1089_met_2023_0265
crossref_primary_10_1007_s10995_011_0758_0
crossref_primary_10_1093_ajcn_nqy006
crossref_primary_10_1017_S0029665110004015
crossref_primary_10_1111_bjd_12914
crossref_primary_10_1080_03007995_2021_1941826
crossref_primary_10_1038_s41430_021_00948_9
crossref_primary_10_1007_s42000_021_00296_0
crossref_primary_10_1016_j_domaniend_2013_12_001
crossref_primary_10_1080_03630242_2020_1862386
crossref_primary_10_1186_s13098_020_00612_5
crossref_primary_10_1016_j_ejcb_2022_151221
crossref_primary_10_1016_j_metabol_2020_154388
crossref_primary_10_1155_2016_6058916
crossref_primary_10_1016_j_jshs_2022_10_001
crossref_primary_10_1161_CIRCHEARTFAILURE_118_005629
crossref_primary_10_1186_1472_6882_13_264
crossref_primary_10_1016_j_pmrj_2010_09_002
crossref_primary_10_3389_fped_2021_705395
crossref_primary_10_1038_s41430_021_00914_5
crossref_primary_10_1186_s12920_021_01050_6
crossref_primary_10_1007_s00421_010_1362_5
crossref_primary_10_3390_ijms23158558
crossref_primary_10_1016_j_cmet_2011_02_005
crossref_primary_10_1097_MCO_0b013e32834ad8b6
crossref_primary_10_1038_s41366_022_01227_8
crossref_primary_10_3390_nu5020498
crossref_primary_10_1111_ijpo_12190
crossref_primary_10_3390_app12094697
crossref_primary_10_1017_S0029665120000038
crossref_primary_10_1038_nutd_2017_13
crossref_primary_10_1007_s00125_010_1768_y
crossref_primary_10_1016_j_exger_2016_02_013
crossref_primary_10_1155_2012_432575
crossref_primary_10_3390_jcm10173955
crossref_primary_10_3390_ph16081134
crossref_primary_10_3390_nu13030993
crossref_primary_10_1016_j_jsbmb_2018_08_010
crossref_primary_10_3390_jcm7120528
crossref_primary_10_1111_cen_12055
crossref_primary_10_1155_2019_5618023
crossref_primary_10_1038_ejcn_2013_6
crossref_primary_10_1155_2020_3496328
crossref_primary_10_1210_jc_2010_1722
crossref_primary_10_5812_ircmj_29382
crossref_primary_10_1007_s12098_021_03815_4
crossref_primary_10_1002_advs_202408763
crossref_primary_10_1007_s11427_024_2695_x
crossref_primary_10_1016_j_phrs_2017_05_013
crossref_primary_10_3390_jpm15060251
crossref_primary_10_1371_journal_pone_0203787
crossref_primary_10_1016_j_numecd_2015_09_004
crossref_primary_10_1186_s12885_016_2445_4
crossref_primary_10_1017_S2040174419000345
crossref_primary_10_1186_s13104_022_06235_5
crossref_primary_10_14814_phy2_13080
crossref_primary_10_3389_fnins_2019_00513
crossref_primary_10_1016_j_jams_2016_02_002
crossref_primary_10_1186_s13148_017_0344_4
crossref_primary_10_3945_ajcn_114_088450
crossref_primary_10_1080_15592294_2018_1518100
crossref_primary_10_1002_cncr_32165
crossref_primary_10_1016_j_exger_2014_04_011
crossref_primary_10_4093_dmj_2017_41_1_51
crossref_primary_10_3892_mmr_2017_7881
crossref_primary_10_1136_bmjopen_2022_065335
crossref_primary_10_1002_ajhb_23143
crossref_primary_10_1016_j_jocd_2015_03_001
crossref_primary_10_2337_db10_0398
crossref_primary_10_1007_s11695_017_2979_9
crossref_primary_10_1155_2014_592642
crossref_primary_10_1186_s42269_018_0001_x
crossref_primary_10_3389_fendo_2017_00202
crossref_primary_10_1038_tp_2013_83
crossref_primary_10_1080_13813455_2017_1295083
crossref_primary_10_1515_hmbci_2018_0014
crossref_primary_10_1177_15578518251379854
crossref_primary_10_2217_clp_12_54
crossref_primary_10_1089_jwh_2016_6128
crossref_primary_10_1016_j_metabol_2015_09_015
crossref_primary_10_4239_wjd_v16_i9_107517
crossref_primary_10_1017_S002966511100084X
crossref_primary_10_1371_journal_pone_0041388
crossref_primary_10_2337_dc09_2361
crossref_primary_10_1111_jocd_13295
crossref_primary_10_4162_nrp_2019_13_6_488
crossref_primary_10_1016_j_dsx_2024_102989
crossref_primary_10_1007_s40618_022_01917_0
crossref_primary_10_1371_journal_pone_0182430
crossref_primary_10_1016_j_dsx_2017_07_022
crossref_primary_10_3390_ijms24020960
crossref_primary_10_3390_genes13040668
crossref_primary_10_1017_S0029665121003815
crossref_primary_10_1016_j_orcp_2009_03_005
crossref_primary_10_1136_bmjopen_2018_023698
crossref_primary_10_1159_000543332
crossref_primary_10_1007_s00247_011_2021_7
crossref_primary_10_1111_aap_12021
crossref_primary_10_3945_ajcn_116_137232
crossref_primary_10_1093_ejendo_lvad014
crossref_primary_10_1007_s12020_020_02186_8
crossref_primary_10_1016_j_clnu_2013_11_001
crossref_primary_10_1016_j_jhep_2014_11_002
crossref_primary_10_1111_pedi_12242
crossref_primary_10_1016_j_cmet_2013_05_020
crossref_primary_10_1160_TH13_04_0285
crossref_primary_10_3109_07853890_2011_605387
crossref_primary_10_4236_health_2013_58A3014
crossref_primary_10_1007_BF03401291
crossref_primary_10_1073_pnas_1019704108
crossref_primary_10_2337_db13_1422
crossref_primary_10_1017_S2040174420000987
crossref_primary_10_1210_jendso_bvad164
crossref_primary_10_1186_2251_6581_13_2
crossref_primary_10_12998_wjcc_v9_i20_5358
crossref_primary_10_1096_fj_202001006RR
crossref_primary_10_4137_LPI_S10805
crossref_primary_10_1136_jim_2016_000155
crossref_primary_10_3389_fonc_2024_1421651
crossref_primary_10_1016_j_coph_2017_08_011
crossref_primary_10_1186_1472_6882_14_248
crossref_primary_10_1530_EJE_22_0509
crossref_primary_10_1007_s11154_017_9411_6
crossref_primary_10_1016_j_arth_2022_03_004
crossref_primary_10_1161_CIRCULATIONAHA_111_067264
crossref_primary_10_1177_1535370213498982
crossref_primary_10_2337_db12_0920
crossref_primary_10_1055_s_0044_1801337
crossref_primary_10_1038_s41366_021_00923_1
crossref_primary_10_1016_j_ghir_2025_101637
crossref_primary_10_1186_s12864_017_3564_2
crossref_primary_10_1111_acel_12564
crossref_primary_10_1016_j_crvi_2016_09_002
crossref_primary_10_1038_s41598_018_29495_3
crossref_primary_10_1038_oby_2009_486
crossref_primary_10_3233_CH_141868
crossref_primary_10_3390_ijms242115588
crossref_primary_10_3390_antiox12061172
crossref_primary_10_3233_CH_141861
crossref_primary_10_1002_jcb_26794
crossref_primary_10_1016_j_nut_2020_110722
crossref_primary_10_1016_j_bcp_2022_114974
crossref_primary_10_1038_hr_2010_267
crossref_primary_10_1080_03014460_2016_1224387
crossref_primary_10_3390_ijerph182111422
crossref_primary_10_1017_S0007114514003730
crossref_primary_10_1038_ncomms15253
crossref_primary_10_1007_s40200_025_01618_4
crossref_primary_10_1016_j_ymeth_2015_03_022
crossref_primary_10_1111_jhn_13041
crossref_primary_10_1017_S0029665111001674
crossref_primary_10_1111_pedi_12276
crossref_primary_10_2337_db10_0697
crossref_primary_10_1177_00033197211038334
crossref_primary_10_1159_000333445
crossref_primary_10_1111_eci_12941
crossref_primary_10_1097_BOR_0000000000000406
crossref_primary_10_1111_obr_12298
crossref_primary_10_1002_ijc_31100
crossref_primary_10_1097_MEG_0000000000001059
crossref_primary_10_3390_metabo10020048
crossref_primary_10_1111_age_13028
crossref_primary_10_1186_1758_5996_6_99
crossref_primary_10_1155_2011_471584
crossref_primary_10_1210_er_2017_00253
crossref_primary_10_1371_journal_pone_0103381
crossref_primary_10_1016_j_bcp_2024_116171
crossref_primary_10_3389_fendo_2021_697223
crossref_primary_10_3390_molecules21111424
crossref_primary_10_1007_s12170_009_0028_5
crossref_primary_10_1016_j_jocd_2019_08_001
crossref_primary_10_3390_nu15245039
crossref_primary_10_1038_s41366_018_0024_2
crossref_primary_10_1016_j_jacl_2016_09_013
crossref_primary_10_1007_s13679_015_0149_8
crossref_primary_10_1371_journal_pone_0091586
crossref_primary_10_1038_nrcardio_2013_35
crossref_primary_10_1038_s42255_022_00620_x
crossref_primary_10_1007_s10522_025_10298_9
crossref_primary_10_1152_physrev_00033_2011
crossref_primary_10_3390_nu14235127
crossref_primary_10_1038_oby_2009_459
crossref_primary_10_1016_j_biopha_2020_110079
crossref_primary_10_1097_QAD_0b013e3283333651
crossref_primary_10_1038_s41366_024_01517_3
crossref_primary_10_1016_j_molmet_2025_102168
crossref_primary_10_1016_j_fertnstert_2012_03_008
crossref_primary_10_3390_nu13113827
crossref_primary_10_3390_nu17121990
crossref_primary_10_1016_j_metabol_2011_09_011
crossref_primary_10_1111_cpf_12402
crossref_primary_10_1186_s12902_022_01023_5
crossref_primary_10_1002_jcp_31008
crossref_primary_10_1007_s11695_017_3099_2
crossref_primary_10_1038_s41430_021_00879_5
crossref_primary_10_1186_2042_6410_3_13
crossref_primary_10_1016_j_physbeh_2017_07_008
crossref_primary_10_1016_S0031_3939_10_70033_0
crossref_primary_10_1183_09031936_00047010
crossref_primary_10_1016_j_trsl_2014_05_008
crossref_primary_10_1038_nutd_2013_25
crossref_primary_10_1186_s12986_016_0159_x
crossref_primary_10_1080_09637486_2020_1851658
crossref_primary_10_1038_s41467_020_16592_z
crossref_primary_10_3390_ijms20235901
crossref_primary_10_1038_s41598_025_86489_8
crossref_primary_10_1111_jdi_12137
crossref_primary_10_1007_s40279_019_01167_w
crossref_primary_10_1038_s42255_022_00597_7
crossref_primary_10_1016_j_clnu_2017_05_012
crossref_primary_10_1016_j_clnu_2017_05_011
crossref_primary_10_3390_nu12030645
crossref_primary_10_1007_s11695_020_04905_6
crossref_primary_10_1016_j_clnesp_2021_03_013
crossref_primary_10_1111_j_1749_6632_2009_05266_x
crossref_primary_10_1016_j_bcdf_2016_01_002
crossref_primary_10_2337_db14_0796
crossref_primary_10_1002_dmrr_2369
crossref_primary_10_3389_fimmu_2018_02945
crossref_primary_10_1371_journal_pone_0197777
crossref_primary_10_1111_cen_13921
crossref_primary_10_3390_nu7115475
crossref_primary_10_1038_s41430_021_00899_1
crossref_primary_10_3390_nu5051544
crossref_primary_10_1007_s00424_009_0752_1
crossref_primary_10_1080_13813455_2016_1202985
crossref_primary_10_1134_S0006297914070086
crossref_primary_10_1111_tmi_13696
crossref_primary_10_3390_nu11010057
crossref_primary_10_1210_jc_2018_02190
crossref_primary_10_1007_s13668_023_00485_w
crossref_primary_10_1002_msj_20206
crossref_primary_10_1167_iovs_62_14_19
crossref_primary_10_1007_s00223_016_0191_x
crossref_primary_10_1016_j_bbalip_2017_06_007
crossref_primary_10_1002_oby_20452
crossref_primary_10_1111_cen_12505
crossref_primary_10_1016_S1665_2681_19_30912_3
crossref_primary_10_1002_oby_23724
crossref_primary_10_1186_s12944_019_0988_5
crossref_primary_10_1371_journal_pone_0203049
crossref_primary_10_1159_000350706
crossref_primary_10_1016_j_chest_2020_05_600
crossref_primary_10_1128_MCB_01106_13
crossref_primary_10_1007_s13668_015_0123_9
crossref_primary_10_1177_0961203316673152
crossref_primary_10_1097_MD_0000000000027114
crossref_primary_10_1111_obr_12406
crossref_primary_10_1179_147683010X12611460763643
crossref_primary_10_3389_fendo_2021_627950
crossref_primary_10_1002_bit_26711
crossref_primary_10_1159_000516680
crossref_primary_10_1016_j_clnu_2012_04_001
crossref_primary_10_1371_journal_pmed_1002985
crossref_primary_10_3390_cells11223540
crossref_primary_10_1186_s12902_020_00559_8
crossref_primary_10_1007_s11690_014_0432_y
crossref_primary_10_1093_ageing_aft005
crossref_primary_10_3389_fimmu_2018_02918
crossref_primary_10_1111_cob_70032
crossref_primary_10_1161_JAHA_119_011541
crossref_primary_10_1038_s41598_018_35369_5
crossref_primary_10_3945_ajcn_112_055772
crossref_primary_10_1002_oby_20033
crossref_primary_10_2188_jea_JE20250025
crossref_primary_10_1097_MD_0000000000040756
crossref_primary_10_1210_jc_2009_2794
crossref_primary_10_1038_nutd_2011_12
crossref_primary_10_1186_1476_511X_13_26
crossref_primary_10_3389_fcvm_2022_844905
crossref_primary_10_1136_bmjdrc_2020_001683
crossref_primary_10_1016_j_dsx_2024_103171
crossref_primary_10_1097_gme_0b013e3181c12b26
crossref_primary_10_1089_met_2010_0075
crossref_primary_10_1007_s11695_025_07746_3
crossref_primary_10_1016_j_jdiacomp_2014_11_003
crossref_primary_10_3389_fcell_2022_1003118
crossref_primary_10_1007_s11695_015_1797_1
crossref_primary_10_1016_j_metabol_2009_11_021
crossref_primary_10_1016_j_tem_2012_02_008
crossref_primary_10_3390_cancers15020485
crossref_primary_10_3389_fcell_2022_983899
crossref_primary_10_1186_s12967_014_0372_1
crossref_primary_10_1007_s00210_018_1530_4
crossref_primary_10_1007_s00431_016_2799_2
crossref_primary_10_1016_j_physbeh_2016_08_019
crossref_primary_10_1289_EHP6886
crossref_primary_10_1177_1178626417703995
crossref_primary_10_4103_ijem_IJEM_251_17
crossref_primary_10_1016_j_numecd_2010_05_005
crossref_primary_10_1016_j_cell_2021_04_015
crossref_primary_10_2337_db10_0830
crossref_primary_10_1016_j_jnutbio_2023_109350
crossref_primary_10_1111_eci_12519
crossref_primary_10_3389_fnut_2025_1616229
crossref_primary_10_3389_fcvm_2020_00091
crossref_primary_10_1038_oby_2012_53
crossref_primary_10_1002_wsbm_1213
crossref_primary_10_3390_nu11123008
crossref_primary_10_1210_jendso_bvac055
crossref_primary_10_1111_eci_12997
crossref_primary_10_3389_fendo_2022_922931
crossref_primary_10_1007_s11306_014_0716_0
crossref_primary_10_1038_s41598_024_68269_y
crossref_primary_10_1038_s41387_024_00260_y
crossref_primary_10_1210_en_2009_1194
crossref_primary_10_1016_j_gde_2018_05_010
crossref_primary_10_1172_JCI129190
crossref_primary_10_1016_j_lfs_2019_117039
crossref_primary_10_1038_oby_2010_60
crossref_primary_10_1186_s12902_017_0176_4
crossref_primary_10_1016_j_clnu_2016_05_006
crossref_primary_10_1016_j_soard_2021_12_005
crossref_primary_10_1007_s11695_010_0200_5
crossref_primary_10_1016_j_cmet_2017_08_002
crossref_primary_10_1016_j_yfrne_2013_08_001
crossref_primary_10_1016_j_ypmed_2015_03_009
crossref_primary_10_3390_ijerph13070743
crossref_primary_10_1016_j_anpedi_2011_03_018
crossref_primary_10_1155_2019_8469739
crossref_primary_10_1007_s11695_019_03879_4
crossref_primary_10_1002_cam4_3925
crossref_primary_10_3390_jcm13020483
crossref_primary_10_2478_v10011_011_0032_4
crossref_primary_10_1002_jcp_27266
crossref_primary_10_3390_ani9100796
crossref_primary_10_2337_db16_0847
crossref_primary_10_1007_s12170_016_0484_7
crossref_primary_10_1016_j_jdiacomp_2015_02_010
crossref_primary_10_1016_j_numecd_2018_03_006
crossref_primary_10_1038_ajh_2010_172
crossref_primary_10_1016_j_mce_2011_07_030
crossref_primary_10_1016_j_pcd_2021_02_002
crossref_primary_10_1093_humupd_dmr020
crossref_primary_10_3389_fphys_2016_00395
crossref_primary_10_1016_j_cmet_2015_01_009
crossref_primary_10_1111_j_2047_6310_2012_00052_x
crossref_primary_10_1089_aid_2013_0020
crossref_primary_10_1016_j_tem_2020_02_009
crossref_primary_10_1007_s11690_017_0555_z
crossref_primary_10_1007_s00535_011_0489_4
crossref_primary_10_1097_XCE_0000000000000154
crossref_primary_10_34172_aim_2022_60
crossref_primary_10_1002_tsm2_59
crossref_primary_10_3390_biomedicines10102615
crossref_primary_10_1038_oby_2011_143
crossref_primary_10_1016_j_jocd_2009_06_002
crossref_primary_10_1002_cam4_3808
crossref_primary_10_3390_biom12060753
crossref_primary_10_3390_obesities5030061
crossref_primary_10_1186_s12944_017_0551_1
crossref_primary_10_1007_s00424_021_02596_1
crossref_primary_10_1016_j_arcmed_2023_102873
crossref_primary_10_1007_s11883_010_0092_9
crossref_primary_10_3389_fped_2020_551103
crossref_primary_10_1016_j_nupar_2020_05_005
crossref_primary_10_3390_ijms26052275
crossref_primary_10_1002_adma_201806695
crossref_primary_10_1016_j_orcp_2015_01_005
crossref_primary_10_1016_j_dsx_2019_06_003
crossref_primary_10_1038_oby_2011_375
crossref_primary_10_1007_s00394_018_1872_1
crossref_primary_10_1016_j_nupar_2018_02_001
crossref_primary_10_1007_s00125_016_3933_4
crossref_primary_10_1038_ejcn_2016_207
crossref_primary_10_1016_j_jocd_2015_04_002
crossref_primary_10_1210_jc_2009_1779
crossref_primary_10_1590_1806_9282_20240049
crossref_primary_10_1038_s41366_020_0528_4
crossref_primary_10_1016_j_peptides_2019_170208
crossref_primary_10_3390_ijms221910541
crossref_primary_10_1136_bmjopen_2019_031969
crossref_primary_10_3389_fendo_2022_929724
crossref_primary_10_1186_s12986_021_00562_3
crossref_primary_10_1002_ajum_12092
crossref_primary_10_1002_oby_23149
crossref_primary_10_1016_j_diabres_2013_12_022
crossref_primary_10_1080_10408398_2024_2437143
crossref_primary_10_1177_0022034512457372
crossref_primary_10_3389_fimmu_2019_02163
crossref_primary_10_1002_ajpa_22357
crossref_primary_10_1007_s11690_009_0188_y
crossref_primary_10_1016_j_carpath_2022_107471
crossref_primary_10_1203_PDR_0b013e31822d7860
crossref_primary_10_1093_europace_euae158
crossref_primary_10_1080_14767058_2017_1419181
crossref_primary_10_1002_ehf2_12761
crossref_primary_10_1038_ijo_2013_202
crossref_primary_10_1093_ageing_afs081
crossref_primary_10_3390_nu14020373
crossref_primary_10_1155_2014_870634
crossref_primary_10_2337_db17_0082
crossref_primary_10_1016_j_ajcnut_2023_11_011
crossref_primary_10_1016_j_tvjl_2010_11_009
crossref_primary_10_3889_oamjms_2022_9708
crossref_primary_10_1038_oby_2011_102
crossref_primary_10_3389_fendo_2018_00709
crossref_primary_10_3389_fcvm_2020_00022
crossref_primary_10_2337_dc12_1452
crossref_primary_10_1016_j_nut_2010_01_004
crossref_primary_10_1515_hmbci_2015_0018
crossref_primary_10_3390_biomedicines9121782
crossref_primary_10_1002_adhm_201600211
crossref_primary_10_1016_j_jped_2020_02_005
crossref_primary_10_1080_10641963_2016_1254226
crossref_primary_10_1080_10408398_2020_1755220
crossref_primary_10_26538_tjnpr_v9i7_40
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1210/jc.2008-1585
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 18987271
Genre Review
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIDDK NIH HHS
  grantid: R01 DK040484
– fundername: NIDDK NIH HHS
  grantid: R37 DK040484
– fundername: NIDDK NIH HHS
  grantid: DK 40484
– fundername: NIDDK NIH HHS
  grantid: R01 DK045343
– fundername: NIDDK NIH HHS
  grantid: DK 45343
GroupedDBID ---
-~X
.55
.GJ
.XZ
08P
0R~
18M
1TH
29K
2WC
34G
354
39C
3O-
4.4
48X
53G
5GY
5RS
5YH
7X7
88E
8F7
8FI
8FJ
AABZA
AACZT
AAIMJ
AAJQQ
AAKAS
AAPGJ
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
AAWDT
AAWTL
AAYJJ
ABBLC
ABDFA
ABDPE
ABEJV
ABGNP
ABJNI
ABLJU
ABMNT
ABNHQ
ABOCM
ABPMR
ABPPZ
ABPQP
ABPTD
ABQNK
ABUWG
ABVGC
ABWST
ABXVV
ABXZS
ACFRR
ACGFO
ACGFS
ACPRK
ACUTJ
ACVCV
ACYHN
ACZBC
ADBBV
ADGKP
ADGZP
ADHKW
ADMTO
ADNBA
ADQBN
ADRTK
ADVEK
ADZCM
AELWJ
AEMDU
AEMQT
AENEX
AENZO
AEOTA
AERZD
AETBJ
AEWNT
AFCHL
AFFNX
AFFQV
AFFZL
AFGWE
AFKRA
AFOFC
AFRAH
AFXAL
AFYAG
AGINJ
AGKRT
AGMDO
AGORE
AGQXC
AGUTN
AHGBF
AHMBA
AHMMS
AI.
AJBYB
AJDVS
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALXQX
APIBT
APJGH
AQDSO
AQKUS
ARIXL
ASPBG
ATGXG
AVNTJ
AVWKF
AZFZN
BAWUL
BAYMD
BCRHZ
BENPR
BEYMZ
BPHCQ
BSWAC
BTRTY
BVXVI
C45
CCPQU
CDBKE
CGR
CS3
CUY
CVF
D-I
DAKXR
DIK
E3Z
EBS
ECM
EIF
EIHJH
EJD
EMOBN
ENERS
F5P
FECEO
FEDTE
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
FYUFA
GAUVT
GJXCC
GX1
H13
HMCUK
HVGLF
HZ~
H~9
IAO
IHR
INH
ITC
J5H
KBUDW
KOP
KSI
KSN
L7B
M1P
M5~
MBLQV
MHKGH
MJL
N4W
N9A
NLBLG
NOMLY
NOYVH
NPM
NU-
NVLIB
O9-
OAUYM
OBFPC
OBH
OCB
ODMLO
OFXIZ
OGEVE
OHH
OJZSN
OK1
OPAEJ
OVD
OVIDX
P2P
P6G
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
REU
ROX
ROZ
TEORI
TJX
TLC
TMA
TR2
TWZ
UKHRP
VH1
VVN
W8F
WHG
WOQ
X52
X7M
YBU
YFH
YHG
YOC
YSK
ZGI
ZXP
ZY1
~02
~H1
7X8
AEHZK
ID FETCH-LOGICAL-c5156-be221e3ff4026c1b52e6690a348e88940e8d9c5abb66379f96bc67b302d2e65d2
IEDL.DBID 7X8
ISICitedReferencesCount 507
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=00004678-200811001-00006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0021-972X
IngestDate Thu Oct 02 11:31:53 EDT 2025
Mon Jul 21 06:06:05 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11 Suppl 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5156-be221e3ff4026c1b52e6690a348e88940e8d9c5abb66379f96bc67b302d2e65d2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
PMID 18987271
PQID 69758575
PQPubID 23479
ParticipantIDs proquest_miscellaneous_69758575
pubmed_primary_18987271
PublicationCentury 2000
PublicationDate 2008-November
PublicationDateYYYYMMDD 2008-11-01
PublicationDate_xml – month: 11
  year: 2008
  text: 2008-November
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The journal of clinical endocrinology and metabolism
PublicationTitleAlternate J Clin Endocrinol Metab
PublicationYear 2008
References 5075509 - J Lipid Res. 1972 Sep;13(5):651-6
1773700 - Diabetes Care. 1991 Dec;14(12):1132-43
9399959 - J Clin Invest. 1997 Dec 15;100(12):3121-30
12226021 - Chest. 2002 Sep;122(3):829-39
1435298 - Metabolism. 1992 Nov;41(11):1242-8
18175737 - Am J Clin Nutr. 2008 Jan;87(1):56-63
18285557 - Diabetes. 2008 May;57(5):1186-94
7593616 - J Clin Invest. 1995 Nov;96(5):2297-303
11850750 - Int J Obes Relat Metab Disord. 2002 Feb;26(2):193-9
2171854 - Clin Sci (Lond). 1990 Oct;79(4):339-48
7616857 - Metabolism. 1995 Jul;44(7):954-9
9572816 - J Appl Physiol (1985). 1998 May;84(5):1674-9
10913047 - Am J Physiol Endocrinol Metab. 2000 Aug;279(2):E455-62
8083357 - J Clin Invest. 1994 Sep;94(3):1172-9
2196039 - Arteriosclerosis. 1990 Jul-Aug;10(4):493-6
5422023 - J Clin Invest. 1970 Jun;49(6):1213-23
15201411 - N Engl J Med. 2004 Jun 17;350(25):2549-57
13990765 - Lancet. 1963 Apr 13;1(7285):785-9
2189893 - J Clin Invest. 1990 Jun;85(6):1844-52
8325992 - J Clin Invest. 1993 Jul;92(1):255-61
3796297 - Metabolism. 1987 Jan;36(1):54-9
7988316 - Diabetes Care. 1994 Sep;17(9):961-9
8491156 - Endocr Rev. 1993 Feb;14(1):72-93
2649512 - J Clin Invest. 1989 Apr;83(4):1168-73
18987272 - J Clin Endocrinol Metab. 2008 Nov;93(11 Suppl 1):S64-73
10780952 - Am J Physiol Endocrinol Metab. 2000 May;278(5):E941-8
16129730 - Obes Res. 2005 Aug;13(8):1466-75
7814610 - J Clin Invest. 1995 Jan;95(1):158-66
9892216 - Diabetes. 1999 Jan;48(1):10-4
10426379 - Diabetes. 1999 Aug;48(8):1600-6
2336074 - N Engl J Med. 1990 May 24;322(21):1477-82
5415680 - J Clin Invest. 1970 Mar;49(3):537-47
8405696 - Diabetes. 1993 Nov;42(11):1567-73
17287467 - Diabetes. 2007 May;56(5):1369-75
17881612 - Diabetes. 2007 Dec;56(12):2878-84
17466309 - Atherosclerosis. 2008 Mar;197(1):164-70
7615840 - J Clin Invest. 1995 Jul;96(1):88-98
16077718 - Int J Obes (Lond). 2005 Dec;29(12):1436-44
1864970 - J Clin Invest. 1991 Aug;88(2):609-13
6138367 - J Clin Invest. 1983 Nov;72(5):1737-47
16804048 - J Clin Endocrinol Metab. 2006 Sep;91(9):3418-25
8764302 - Am J Physiol. 1996 Jun;270(6 Pt 2):R1340-6
7938225 - Physiol Rev. 1994 Oct;74(4):761-811
1542265 - Metabolism. 1992 Mar;41(3):264-72
1669488 - Ann Epidemiol. 1990 Oct;1(1):33-48
15173884 - J Clin Invest. 2004 Jun;113(11):1582-8
15507534 - Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E547-55
2573554 - Diabetes. 1989 Dec;38(12):1595-601
10909983 - Diabetes. 2000 Jul;49(7):1231-8
11350782 - Am J Physiol Endocrinol Metab. 2001 Jun;280(6):E1000-6
9874618 - N Engl J Med. 1998 Dec 24;339(26):1946-7
9098178 - Am J Epidemiol. 1997 Apr 1;145(7):614-9
17287468 - Diabetes. 2007 Apr;56(4):1010-3
7009368 - Horm Metab Res. 1980 Dec;12(12):688-94
10426377 - Diabetes. 1999 Aug;48(8):1586-92
10973236 - Nat Genet. 2000 Sep;26(1):13
11053362 - J Appl Physiol (1985). 2000 Nov;89(5):2057-64
12915396 - Am J Physiol Endocrinol Metab. 2003 Dec;285(6):E1282-8
2112480 - Eur J Clin Invest. 1990 Apr;20(2):158-65
11872676 - Diabetes. 2002 Mar;51(3):755-61
18212276 - Circulation. 2008 Feb 5;117(5):605-13
8326021 - J Clin Invest. 1993 Jul;92(1):91-8
187517 - Diabetologia. 1976 Dec;12(6):563-71
2647436 - Diabetes Metab Rev. 1989 Mar;5(2):83-109
8582538 - Diabetologia. 1995 Nov;38(11):1295-9
10078552 - Diabetes. 1999 Mar;48(3):524-30
18842804 - Am J Clin Nutr. 2008 Oct;88(4):1134-41
17199713 - Diabetes Obes Metab. 2007 Jan;9(1):1-10
2202881 - Metabolism. 1990 Sep;39(9):897-901
14578253 - Diabetes Care. 2003 Nov;26(11):3148-52
12671047 - J Clin Invest. 2003 Apr;111(7):981-8
1872918 - Atherosclerosis. 1991 Feb;86(2-3):251-60
12736157 - Am J Physiol Endocrinol Metab. 2003 Jun;284(6):E1140-8
9486980 - J Clin Invest. 1998 Mar 1;101(5):1094-101
11288037 - Metabolism. 2001 Apr;50(4):425-35
7840063 - Am J Clin Nutr. 1995 Feb;61(2):274-8
16323003 - Diabetologia. 2006 Jan;49(1):149-57
10731493 - Am J Clin Nutr. 2000 Apr;71(4):885-92
18355813 - Gastroenterology. 2008 May;134(5):1369-75
9916137 - J Clin Invest. 1999 Jan;103(2):253-9
16571861 - Obesity (Silver Spring). 2006 Feb;14(2):336-41
16087993 - Am J Clin Nutr. 2005 Aug;82(2):456-66
14747216 - Diabetes Care. 2004 Feb;27(2):372-7
17664244 - Diabetes. 2007 Oct;56(10):2589-97
17161228 - Metabolism. 2007 Jan;56(1):68-76
References_xml – reference: 13990765 - Lancet. 1963 Apr 13;1(7285):785-9
– reference: 11288037 - Metabolism. 2001 Apr;50(4):425-35
– reference: 8325992 - J Clin Invest. 1993 Jul;92(1):255-61
– reference: 16077718 - Int J Obes (Lond). 2005 Dec;29(12):1436-44
– reference: 15201411 - N Engl J Med. 2004 Jun 17;350(25):2549-57
– reference: 1435298 - Metabolism. 1992 Nov;41(11):1242-8
– reference: 2202881 - Metabolism. 1990 Sep;39(9):897-901
– reference: 17199713 - Diabetes Obes Metab. 2007 Jan;9(1):1-10
– reference: 7593616 - J Clin Invest. 1995 Nov;96(5):2297-303
– reference: 18355813 - Gastroenterology. 2008 May;134(5):1369-75
– reference: 10078552 - Diabetes. 1999 Mar;48(3):524-30
– reference: 12671047 - J Clin Invest. 2003 Apr;111(7):981-8
– reference: 1773700 - Diabetes Care. 1991 Dec;14(12):1132-43
– reference: 8764302 - Am J Physiol. 1996 Jun;270(6 Pt 2):R1340-6
– reference: 10426379 - Diabetes. 1999 Aug;48(8):1600-6
– reference: 12736157 - Am J Physiol Endocrinol Metab. 2003 Jun;284(6):E1140-8
– reference: 12915396 - Am J Physiol Endocrinol Metab. 2003 Dec;285(6):E1282-8
– reference: 7938225 - Physiol Rev. 1994 Oct;74(4):761-811
– reference: 10731493 - Am J Clin Nutr. 2000 Apr;71(4):885-92
– reference: 2112480 - Eur J Clin Invest. 1990 Apr;20(2):158-65
– reference: 2647436 - Diabetes Metab Rev. 1989 Mar;5(2):83-109
– reference: 18175737 - Am J Clin Nutr. 2008 Jan;87(1):56-63
– reference: 2649512 - J Clin Invest. 1989 Apr;83(4):1168-73
– reference: 9874618 - N Engl J Med. 1998 Dec 24;339(26):1946-7
– reference: 8083357 - J Clin Invest. 1994 Sep;94(3):1172-9
– reference: 1542265 - Metabolism. 1992 Mar;41(3):264-72
– reference: 7814610 - J Clin Invest. 1995 Jan;95(1):158-66
– reference: 11350782 - Am J Physiol Endocrinol Metab. 2001 Jun;280(6):E1000-6
– reference: 2189893 - J Clin Invest. 1990 Jun;85(6):1844-52
– reference: 16087993 - Am J Clin Nutr. 2005 Aug;82(2):456-66
– reference: 187517 - Diabetologia. 1976 Dec;12(6):563-71
– reference: 18285557 - Diabetes. 2008 May;57(5):1186-94
– reference: 1669488 - Ann Epidemiol. 1990 Oct;1(1):33-48
– reference: 8491156 - Endocr Rev. 1993 Feb;14(1):72-93
– reference: 14747216 - Diabetes Care. 2004 Feb;27(2):372-7
– reference: 18212276 - Circulation. 2008 Feb 5;117(5):605-13
– reference: 16571861 - Obesity (Silver Spring). 2006 Feb;14(2):336-41
– reference: 14578253 - Diabetes Care. 2003 Nov;26(11):3148-52
– reference: 1872918 - Atherosclerosis. 1991 Feb;86(2-3):251-60
– reference: 8326021 - J Clin Invest. 1993 Jul;92(1):91-8
– reference: 15507534 - Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E547-55
– reference: 11850750 - Int J Obes Relat Metab Disord. 2002 Feb;26(2):193-9
– reference: 1864970 - J Clin Invest. 1991 Aug;88(2):609-13
– reference: 2573554 - Diabetes. 1989 Dec;38(12):1595-601
– reference: 6138367 - J Clin Invest. 1983 Nov;72(5):1737-47
– reference: 7988316 - Diabetes Care. 1994 Sep;17(9):961-9
– reference: 16804048 - J Clin Endocrinol Metab. 2006 Sep;91(9):3418-25
– reference: 12226021 - Chest. 2002 Sep;122(3):829-39
– reference: 8405696 - Diabetes. 1993 Nov;42(11):1567-73
– reference: 3796297 - Metabolism. 1987 Jan;36(1):54-9
– reference: 7615840 - J Clin Invest. 1995 Jul;96(1):88-98
– reference: 2171854 - Clin Sci (Lond). 1990 Oct;79(4):339-48
– reference: 10973236 - Nat Genet. 2000 Sep;26(1):13
– reference: 17287467 - Diabetes. 2007 May;56(5):1369-75
– reference: 17466309 - Atherosclerosis. 2008 Mar;197(1):164-70
– reference: 2196039 - Arteriosclerosis. 1990 Jul-Aug;10(4):493-6
– reference: 5422023 - J Clin Invest. 1970 Jun;49(6):1213-23
– reference: 9572816 - J Appl Physiol (1985). 1998 May;84(5):1674-9
– reference: 15173884 - J Clin Invest. 2004 Jun;113(11):1582-8
– reference: 9399959 - J Clin Invest. 1997 Dec 15;100(12):3121-30
– reference: 9916137 - J Clin Invest. 1999 Jan;103(2):253-9
– reference: 16323003 - Diabetologia. 2006 Jan;49(1):149-57
– reference: 9098178 - Am J Epidemiol. 1997 Apr 1;145(7):614-9
– reference: 10909983 - Diabetes. 2000 Jul;49(7):1231-8
– reference: 5075509 - J Lipid Res. 1972 Sep;13(5):651-6
– reference: 10913047 - Am J Physiol Endocrinol Metab. 2000 Aug;279(2):E455-62
– reference: 18842804 - Am J Clin Nutr. 2008 Oct;88(4):1134-41
– reference: 17161228 - Metabolism. 2007 Jan;56(1):68-76
– reference: 11053362 - J Appl Physiol (1985). 2000 Nov;89(5):2057-64
– reference: 2336074 - N Engl J Med. 1990 May 24;322(21):1477-82
– reference: 7840063 - Am J Clin Nutr. 1995 Feb;61(2):274-8
– reference: 5415680 - J Clin Invest. 1970 Mar;49(3):537-47
– reference: 8582538 - Diabetologia. 1995 Nov;38(11):1295-9
– reference: 7009368 - Horm Metab Res. 1980 Dec;12(12):688-94
– reference: 9486980 - J Clin Invest. 1998 Mar 1;101(5):1094-101
– reference: 10426377 - Diabetes. 1999 Aug;48(8):1586-92
– reference: 16129730 - Obes Res. 2005 Aug;13(8):1466-75
– reference: 17664244 - Diabetes. 2007 Oct;56(10):2589-97
– reference: 7616857 - Metabolism. 1995 Jul;44(7):954-9
– reference: 17881612 - Diabetes. 2007 Dec;56(12):2878-84
– reference: 9892216 - Diabetes. 1999 Jan;48(1):10-4
– reference: 18987272 - J Clin Endocrinol Metab. 2008 Nov;93(11 Suppl 1):S64-73
– reference: 17287468 - Diabetes. 2007 Apr;56(4):1010-3
– reference: 11872676 - Diabetes. 2002 Mar;51(3):755-61
– reference: 10780952 - Am J Physiol Endocrinol Metab. 2000 May;278(5):E941-8
SSID ssj0014453
Score 2.4983683
SecondaryResourceType review_article
Snippet An upper body/visceral fat distribution in obesity is closely linked with metabolic complications, whereas increased lower body fat is independently predictive...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage S57
SubjectTerms Adipose Tissue - physiology
Body Fat Distribution
Fatty Acids - metabolism
Humans
Intra-Abdominal Fat - physiology
Metabolic Diseases - etiology
Obesity - complications
Obesity - metabolism
Obesity - physiopathology
Title Role of body fat distribution and the metabolic complications of obesity
URI https://www.ncbi.nlm.nih.gov/pubmed/18987271
https://www.proquest.com/docview/69758575
Volume 93
WOSCitedRecordID wos00004678-200811001-00006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JSwMxFH5UK-LFfalrDl6DnSWZBAQRsfTSUkRhbsNkg0qdqbYK_ntfZkE8iAcvc5rA8PJN3vfylg_g0vBQeTdOrXGMYvwlaR70FdUmj1SfIWykqsQmkvFYpKmcdOC67YXxZZXtmVgd1KbU_o78ikvPbBN2M3-lXjPK51YbAY0V6EZIZDymk_Q7hxDHzQxKX4SQhGlT9u57Vp6r4YUYPjHBfqeWlYsZbP3v47Zhs6GW5LbGwg50bLEL66Mmeb4Hw4dyZknpiCrNJ3H5khg_NbcRvCJ5YQiyQfJilwiM2VSTH-XmfmFZqwjsw9Pg_vFuSBshBaqRrnCqbBgGNnIOg0WuA8VCyzEqzqNYWCFk3LfCSM1ypZB_JNJJrjRPVNQPDb7JTHgAq0VZ2CMgiml08r57VQaxlokKHUZUhlvnlEMu1oOL1kIZAtVnH_LClu-LrLVRDw5rI2fzep5GFggpkEYFx3-uPYGNet_8FcgpdB3-ovYM1vTHcrp4O6_2H5_jyegLjyW6NQ
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+body+fat+distribution+and+the+metabolic+complications+of+obesity&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Jensen%2C+Michael+D&rft.date=2008-11-01&rft.issn=0021-972X&rft.volume=93&rft.issue=11+Suppl+1&rft.spage=S57&rft_id=info:doi/10.1210%2Fjc.2008-1585&rft_id=info%3Apmid%2F18987271&rft_id=info%3Apmid%2F18987271&rft.externalDocID=18987271
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon